Gardasil demand in China sinks, and Merck expects the same next quarter

Mer­ck said sales of its HPV vac­cine Gar­dasil — its sec­ond-largest prod­uct — dipped again in the third quar­ter, cit­ing re­duced de­mand in Chi­na, where the shot …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.